Dalian Bio-Chem Co Ltd Strategic Asset Allocation Index
Dalian Bio-Chem Co Ltd strategic asset allocation index. Dalian Bio-Chem Co Ltd (603360) has a Strategic Asset Allocation Index of 42.0% as of June 2023. Strategic assets (PP&E of CN¥614.40 Million plus long-term investments of CN¥-) total CN¥614.40 Million, measured against net assets of CN¥1.46 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Dalian Bio-Chem Co Ltd net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Dalian Bio-Chem Co Ltd (2011–2021)
Strategic asset allocation index of Dalian Bio-Chem Co Ltd from 2011 to 2021. This chart shows how Dalian Bio-Chem Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of June 2023, the index stands at 42.0%, representing strategic assets of CN¥614.40 Million against net assets of CN¥1.46 Billion CNY. Check tangible net worth ratio of Dalian Bio-Chem Co Ltd to evaluate the tangible quality of the company's equity base.
Dalian Bio-Chem Co Ltd Strategic Asset Allocation Index by Year (2011–2021)
Dalian Bio-Chem Co Ltd strategic asset allocation index by year from 2011 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Dalian Bio-Chem Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603360 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 78.7% | CN¥825.83 Million | CN¥825.83 Million | CN¥- | CN¥1.05 Billion | ▲ +23.8 pp |
| 2020 | 54.9% | CN¥542.56 Million | CN¥542.56 Million | CN¥- | CN¥988.28 Million | ▲ +1.0 pp |
| 2019 | 53.9% | CN¥557.24 Million | CN¥425.62 Million | CN¥131.61 Million | CN¥1.03 Billion | ▼ -5.1 pp |
| 2018 | 59.0% | CN¥470.76 Million | CN¥340.76 Million | CN¥130.00 Million | CN¥798.03 Million | ▲ +22.5 pp |
| 2017 | 36.5% | CN¥250.31 Million | CN¥250.31 Million | CN¥- | CN¥686.42 Million | ▼ -17.8 pp |
| 2016 | 54.2% | CN¥248.37 Million | CN¥248.37 Million | CN¥- | CN¥458.09 Million | ▼ -20.3 pp |
| 2015 | 74.5% | CN¥268.26 Million | CN¥268.26 Million | CN¥- | CN¥360.17 Million | ▼ -15.0 pp |
| 2014 | 89.5% | CN¥271.41 Million | CN¥271.41 Million | CN¥- | CN¥303.16 Million | ▼ -2.4 pp |
| 2013 | 92.0% | CN¥254.89 Million | CN¥254.89 Million | CN¥- | CN¥277.14 Million | ▼ -15.0 pp |
| 2012 | 107.0% | CN¥244.20 Million | CN¥244.20 Million | CN¥- | CN¥228.22 Million | ▼ -18.8 pp |
| 2011 | 125.8% | CN¥230.75 Million | CN¥230.75 Million | CN¥- | CN¥183.41 Million | — |